The present study shows that all three isoforms of NOS are expressed in human ovarian cancer cells and that the NOSs are differentially expressed in CDDP-sensitive and CDDP-resistant cells, suggesting potential involvement in chemoresistance. This evidence concerns the gene NOS2 and ovarian carcinoma.